Conjugate Vaccine Market Research Report by Type (Monovalent and Multivalent), by Indication (Diphtheria and Pertussis, Influenza, Meningococcal, and Pneumococcal), by Pathogen Type, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Conjugate Vaccine Market is expected to grow from USD 29,406.16 Million in 2020 to USD 46,902.47 Million by the end of 2025.
2. The Global Conjugate Vaccine Market is expected to grow from EUR 25,783.88 Million in 2020 to EUR 41,124.97 Million by the end of 2025.
3. The Global Conjugate Vaccine Market is expected to grow from GBP 22,921.92 Million in 2020 to GBP 36,560.19 Million by the end of 2025.
4. The Global Conjugate Vaccine Market is expected to grow from JPY 3,138,383.05 Million in 2020 to JPY 5,005,682.10 Million by the end of 2025.
5. The Global Conjugate Vaccine Market is expected to grow from AUD 42,701.66 Million in 2020 to AUD 68,108.62 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Conjugate Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Conjugate Vaccine Market studied across Monovalent and Multivalent.
Based on Indication, the Conjugate Vaccine Market studied across Diphtheria and Pertussis, Influenza, Meningococcal, and Pneumococcal.
Based on Pathogen Type, the Conjugate Vaccine Market studied across Bacterial Conjugate Vaccine, Combination Conjugate Vaccine, and Viral Conjugate Vaccine.
Based on End User, the Conjugate Vaccine Market studied across Adults Conjugate Vaccine and Pediatrics Conjugate Vaccine.
Based on Geography, the Conjugate Vaccine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Conjugate Vaccine Market including Bharat Biotech, Biological E. Ltd, CSL Limited, GlaxoSmithKline, plc., Merck and Company, Novartis AG, Nuron Biotech Inc., Pfizer, Inc., Sanofi Pasteur, and Serum Institute of India.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Conjugate Vaccine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Conjugate Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Conjugate Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Conjugate Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Conjugate Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Conjugate Vaccine Market?
6. What are the modes and strategic moves considered suitable for entering the Global Conjugate Vaccine Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Conjugate Vaccine Market is expected to grow from USD 29,406.16 Million in 2020 to USD 46,902.47 Million by the end of 2025.
2. The Global Conjugate Vaccine Market is expected to grow from EUR 25,783.88 Million in 2020 to EUR 41,124.97 Million by the end of 2025.
3. The Global Conjugate Vaccine Market is expected to grow from GBP 22,921.92 Million in 2020 to GBP 36,560.19 Million by the end of 2025.
4. The Global Conjugate Vaccine Market is expected to grow from JPY 3,138,383.05 Million in 2020 to JPY 5,005,682.10 Million by the end of 2025.
5. The Global Conjugate Vaccine Market is expected to grow from AUD 42,701.66 Million in 2020 to AUD 68,108.62 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Conjugate Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Conjugate Vaccine Market studied across Monovalent and Multivalent.
Based on Indication, the Conjugate Vaccine Market studied across Diphtheria and Pertussis, Influenza, Meningococcal, and Pneumococcal.
Based on Pathogen Type, the Conjugate Vaccine Market studied across Bacterial Conjugate Vaccine, Combination Conjugate Vaccine, and Viral Conjugate Vaccine.
Based on End User, the Conjugate Vaccine Market studied across Adults Conjugate Vaccine and Pediatrics Conjugate Vaccine.
Based on Geography, the Conjugate Vaccine Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Conjugate Vaccine Market including Bharat Biotech, Biological E. Ltd, CSL Limited, GlaxoSmithKline, plc., Merck and Company, Novartis AG, Nuron Biotech Inc., Pfizer, Inc., Sanofi Pasteur, and Serum Institute of India.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Conjugate Vaccine Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Conjugate Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Conjugate Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Conjugate Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Conjugate Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Conjugate Vaccine Market?
6. What are the modes and strategic moves considered suitable for entering the Global Conjugate Vaccine Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Indication Outlook
3.5. End User Outlook
3.6. Pathogen Type Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL CONJUGATE VACCINE MARKET, BY TYPE
6.1. Introduction
6.2. Monovalent
6.3. Multivalent
7. GLOBAL CONJUGATE VACCINE MARKET, BY INDICATION
7.1. Introduction
7.2. Diphtheria and Pertussis
7.3. Influenza
7.4. Meningococcal
7.5. Pneumococcal
8. GLOBAL CONJUGATE VACCINE MARKET, BY PATHOGEN TYPE
8.1. Introduction
8.2. Bacterial Conjugate Vaccine
8.3. Combination Conjugate Vaccine
8.4. Viral Conjugate Vaccine
9. GLOBAL CONJUGATE VACCINE MARKET, BY END USER
9.1. Introduction
9.2. Adults Conjugate Vaccine
9.3. Pediatrics Conjugate Vaccine
10. AMERICAS CONJUGATE VACCINE MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC CONJUGATE VACCINE MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Bharat Biotech
14.2. Biological E. Ltd
14.3. CSL Limited
14.4. GlaxoSmithKline, plc.
14.5. Merck and Company
14.6. Novartis AG
14.7. Nuron Biotech Inc.
14.8. Pfizer, Inc.
14.9. Sanofi Pasteur
14.10. Serum Institute of India
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Indication Outlook
3.5. End User Outlook
3.6. Pathogen Type Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL CONJUGATE VACCINE MARKET, BY TYPE
6.1. Introduction
6.2. Monovalent
6.3. Multivalent
7. GLOBAL CONJUGATE VACCINE MARKET, BY INDICATION
7.1. Introduction
7.2. Diphtheria and Pertussis
7.3. Influenza
7.4. Meningococcal
7.5. Pneumococcal
8. GLOBAL CONJUGATE VACCINE MARKET, BY PATHOGEN TYPE
8.1. Introduction
8.2. Bacterial Conjugate Vaccine
8.3. Combination Conjugate Vaccine
8.4. Viral Conjugate Vaccine
9. GLOBAL CONJUGATE VACCINE MARKET, BY END USER
9.1. Introduction
9.2. Adults Conjugate Vaccine
9.3. Pediatrics Conjugate Vaccine
10. AMERICAS CONJUGATE VACCINE MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC CONJUGATE VACCINE MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Bharat Biotech
14.2. Biological E. Ltd
14.3. CSL Limited
14.4. GlaxoSmithKline, plc.
14.5. Merck and Company
14.6. Novartis AG
14.7. Nuron Biotech Inc.
14.8. Pfizer, Inc.
14.9. Sanofi Pasteur
14.10. Serum Institute of India
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MONOVALENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MULTIVALENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DIPHTHERIA AND PERTUSSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INFLUENZA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY BACTERIAL CONJUGATE VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COMBINATION CONJUGATE VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY VIRAL CONJUGATE VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADULTS CONJUGATE VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PEDIATRICS CONJUGATE VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. CANADA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CANADA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MEXICO CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. CHINA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. CHINA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. CHINA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. INDIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. INDIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. JAPAN CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. JAPAN CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. JAPAN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. JAPAN CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. THAILAND CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. THAILAND CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. THAILAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. THAILAND CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. FRANCE CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. FRANCE CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. FRANCE CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. FRANCE CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. GERMANY CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. GERMANY CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. GERMANY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. GERMANY CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. ITALY CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. ITALY CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. ITALY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. ITALY CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. QATAR CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. QATAR CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. QATAR CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. QATAR CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SPAIN CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SPAIN CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SPAIN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SPAIN CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. GLOBAL CONJUGATE VACCINE MARKET: SCORES
TABLE 135. GLOBAL CONJUGATE VACCINE MARKET: BUSINESS STRATEGY
TABLE 136. GLOBAL CONJUGATE VACCINE MARKET: PRODUCT SATISFACTION
TABLE 137. GLOBAL CONJUGATE VACCINE MARKET: RANKING
TABLE 138. GLOBAL CONJUGATE VACCINE MARKET: MERGER & ACQUISITION
TABLE 139. GLOBAL CONJUGATE VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 140. GLOBAL CONJUGATE VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 141. GLOBAL CONJUGATE VACCINE MARKET: INVESTMENT & FUNDING
TABLE 142. GLOBAL CONJUGATE VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 143. GLOBAL CONJUGATE VACCINE MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MONOVALENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MULTIVALENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DIPHTHERIA AND PERTUSSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INFLUENZA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY BACTERIAL CONJUGATE VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COMBINATION CONJUGATE VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY VIRAL CONJUGATE VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADULTS CONJUGATE VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PEDIATRICS CONJUGATE VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. CANADA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CANADA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MEXICO CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. CHINA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. CHINA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. CHINA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. INDIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. INDIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. JAPAN CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. JAPAN CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. JAPAN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. JAPAN CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. THAILAND CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. THAILAND CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. THAILAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. THAILAND CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. FRANCE CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. FRANCE CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. FRANCE CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. FRANCE CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. GERMANY CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. GERMANY CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. GERMANY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. GERMANY CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. ITALY CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. ITALY CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. ITALY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. ITALY CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. QATAR CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. QATAR CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. QATAR CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. QATAR CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SPAIN CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SPAIN CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SPAIN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SPAIN CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. GLOBAL CONJUGATE VACCINE MARKET: SCORES
TABLE 135. GLOBAL CONJUGATE VACCINE MARKET: BUSINESS STRATEGY
TABLE 136. GLOBAL CONJUGATE VACCINE MARKET: PRODUCT SATISFACTION
TABLE 137. GLOBAL CONJUGATE VACCINE MARKET: RANKING
TABLE 138. GLOBAL CONJUGATE VACCINE MARKET: MERGER & ACQUISITION
TABLE 139. GLOBAL CONJUGATE VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 140. GLOBAL CONJUGATE VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 141. GLOBAL CONJUGATE VACCINE MARKET: INVESTMENT & FUNDING
TABLE 142. GLOBAL CONJUGATE VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 143. GLOBAL CONJUGATE VACCINE MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL CONJUGATE VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CONJUGATE VACCINE MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2020 (USD MILLION)
FIGURE 8. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL CONJUGATE VACCINE MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL CONJUGATE VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 16. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2025
FIGURE 18. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MONOVALENT, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MULTIVALENT, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 21. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2025
FIGURE 23. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DIPHTHERIA AND PERTUSSIS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INFLUENZA, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2020 VS 2025 (%)
FIGURE 28. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2025
FIGURE 30. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY BACTERIAL CONJUGATE VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COMBINATION CONJUGATE VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY VIRAL CONJUGATE VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 34. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025
FIGURE 36. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADULTS CONJUGATE VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PEDIATRICS CONJUGATE VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 38. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. CANADA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. MEXICO CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 47. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. CHINA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. INDIA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. JAPAN CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. THAILAND CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 61. FRANCE CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. GERMANY CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. ITALY CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. QATAR CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SPAIN CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. GLOBAL CONJUGATE VACCINE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 73. GLOBAL CONJUGATE VACCINE MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 74. GLOBAL CONJUGATE VACCINE MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CONJUGATE VACCINE MARKET, BY TYPE
FIGURE 1. GLOBAL CONJUGATE VACCINE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL CONJUGATE VACCINE MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2020 (USD MILLION)
FIGURE 8. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL CONJUGATE VACCINE MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL CONJUGATE VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 16. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TYPE, 2025
FIGURE 18. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MONOVALENT, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MULTIVALENT, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 21. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INDICATION, 2025
FIGURE 23. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DIPHTHERIA AND PERTUSSIS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INFLUENZA, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2020 VS 2025 (%)
FIGURE 28. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PATHOGEN TYPE, 2025
FIGURE 30. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY BACTERIAL CONJUGATE VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COMBINATION CONJUGATE VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY VIRAL CONJUGATE VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 34. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2025
FIGURE 36. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADULTS CONJUGATE VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PEDIATRICS CONJUGATE VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 38. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. CANADA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. MEXICO CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 47. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. CHINA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. INDIA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. JAPAN CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. THAILAND CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 61. FRANCE CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. GERMANY CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. ITALY CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. QATAR CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SPAIN CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. GLOBAL CONJUGATE VACCINE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 73. GLOBAL CONJUGATE VACCINE MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 74. GLOBAL CONJUGATE VACCINE MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CONJUGATE VACCINE MARKET, BY TYPE
